Functional and Behavioral Characterization of Central Amygdala Glucagon Like Peptode-1 Receptors
中央杏仁核胰高血糖素样 Peptode-1 受体的功能和行为特征
基本信息
- 批准号:10414577
- 负责人:
- 金额:$ 5.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAgonistAmygdaloid structureAnatomyAnimalsAnteriorAppetitive BehaviorApplications GrantsBehaviorBehavioralBehavioral AssayBiological AssayBrainCellsClosure by clampConsummatory BehaviorCoupledDataDesire for foodDevicesDrug TargetingEatingEating BehaviorElectric CapacitanceElectrophysiology (science)FastingFeeding behaviorsFiberFluorescenceFoodFood deprivation (experimental)GLP-I receptorGTP-Binding Protein alpha Subunits, GsGeneticGlucagonGoalsHigh Fat DietImageLaboratory miceLearningMasticationMeasuresMediatingMembraneMembrane PotentialsMentorsMotivationMusNeuronsNon-Insulin-Dependent Diabetes MellitusNoseOperative Surgical ProceduresPalateParentsPeripheralPharmaceutical PreparationsPhasePhotometryPhysiologyPopulationProceduresPropertyReceptor ActivationReporterResearchResistanceRestRoleSatiationSiteSliceSodium Channel BlockersSynaptic TransmissionSystemTestingTimeTrainingVirusWorkeffective therapyexenatidefeedingfood consumptionin vivominiaturizeneural circuitneurophysiologynovelobesity treatmentparent grantpatch clampreceptorreceptor functionrecruitrelating to nervous systemresponsevoltage
项目摘要
Summary of Parent Grant
Drugs that target glucagon-like peptide 1 receptor (GLP-1R) systems are commonly prescribed for the
treatment of type II diabetes. Unfortunately, we do not yet fully understand how these drugs work on targets in
the brain or how brain GLP-1Rs regulate eating behaviors. In this proposal, we will characterize the functional
role of GLP-1Rs in the central amygdala (CeA) using neural circuit, genetic, and behavioral approaches in
laboratory mice. The parent grant proposal will test the functional requirements of GLP-1Rs neurons in
mediating its activation, the endogenous role of CeA GLP-1Rs in food intake, and the role of CeA GLP-1Rs in
mediating the actions of peripherallyadministered agonists.
The parent grant will characterize: the functional role of CeA GLP-1Rs in regulating neural activity and neural
responses to peripherally applied GLP-1R agonists (Aim 1) and determine if CeA GLP- 1Rs are required for
the anorexigenic effects of peripherally administered GLP-1R agonists using two separate paradigms: fasting-
induced refeed and intermittent access to high fat diet (Aim 2). Specifically, we will utilize in vivo Ca2+ fiber
photometry in combination with 1) local deletion of CeA GLP-1Rs and 2) local CeA administration of GLP-1R
agonists. Site-specific genetic deletion of CeA GLP-1Rs in combination with longitudinal assessment of
feeding using miniaturized feeding devices adapted for operant feeding (Aim 2).
Functionally, we hypothesize that CeA GLP-1Rs are required for the neurophysiological effects of
peripherally administered GLP-1R agonists on the CeA and that direct activation of CeA GLP- 1Rs is
sufficient to induce robust changes in CeA neural activity in vivo. Behaviorally, we hypothesize that CeA
GLP-1Rs drive motivation and appetitive behavior for palatable food and that deletion of these receptors will
partially suppress the effects of peripherally administrated GLP-1R agonists on binge-like food intake. The
significance of the parent proposal is to discern the contribution of the brain’s endogenous GLP-1R system
to better inform more effective treatments for obesity and type II diabetes.
The overarching hypothesis is that CeA GLP-1Rs function endogenously to constrain large volume food
intake, motivation for palatable food, and are partially required for the anorexigenic effects of peripheral
GLP-1R agonists on food intake.
家长补助金摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Andrew Hardaway其他文献
James Andrew Hardaway的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Andrew Hardaway', 18)}}的其他基金
Functional and Behavioral Characterization of Central Amygdala Glucagon Like Peptode-1 Receptors
中央杏仁核胰高血糖素样 Peptode-1 受体的功能和行为特征
- 批准号:
10286169 - 财政年份:2021
- 资助金额:
$ 5.03万 - 项目类别:
Functional and Behavioral Characterization of Central Amygdala Glucagon Like Peptode-1 Receptors
中央杏仁核胰高血糖素样 Peptode-1 受体的功能和行为特征
- 批准号:
10414117 - 财政年份:2021
- 资助金额:
$ 5.03万 - 项目类别:
Functional and Behavioral Characterization of Central Amygdala Glucagon Like Peptode-1 Receptors
中央杏仁核胰高血糖素样 Peptode-1 受体的功能和行为特征
- 批准号:
10502881 - 财政年份:2021
- 资助金额:
$ 5.03万 - 项目类别:
A Nociceptin Central Amygdala to Hindbrain Circuit for the Control of Palatable Food Consumption
用于控制可口食物消耗的伤害感受肽中央杏仁核到后脑回路
- 批准号:
10103903 - 财政年份:2020
- 资助金额:
$ 5.03万 - 项目类别:
A Nociceptin Central Amygdala to Hindbrain Circuit for the Control of Palatable Food Consumption
用于控制可口食物消耗的伤害感受肽中央杏仁核到后脑回路
- 批准号:
10413010 - 财政年份:2020
- 资助金额:
$ 5.03万 - 项目类别:
A Nociceptin Central Amygdala to Hindbrain Circuit for the Control of Palatable Food Consumption
用于控制可口食物消耗的伤害感受肽中央杏仁核到后脑回路
- 批准号:
10159256 - 财政年份:2020
- 资助金额:
$ 5.03万 - 项目类别:
Presynaptic Mechanisms Regulating the Dopamine Transporter
调节多巴胺转运蛋白的突触前机制
- 批准号:
8207320 - 财政年份:2010
- 资助金额:
$ 5.03万 - 项目类别:
Presynaptic Mechanisms Regulating the Dopamine Transporter
调节多巴胺转运蛋白的突触前机制
- 批准号:
8061759 - 财政年份:2010
- 资助金额:
$ 5.03万 - 项目类别:
Presynaptic Mechanisms Regulating the Dopamine Transporter
调节多巴胺转运蛋白的突触前机制
- 批准号:
8387035 - 财政年份:2010
- 资助金额:
$ 5.03万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 5.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 5.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 5.03万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 5.03万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 5.03万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 5.03万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 5.03万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 5.03万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 5.03万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 5.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




